AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
27min chapter
250. When You Should Worry About LDL Cholesterol with Mike Fave
Paul Saladino MD podcast
Discussion on PCSK9 Inhibitors and Statins
The chapter analyzes the efficacy and risks of PCSK9 inhibitors like evolocumab and alirocumab, comparing them to statins in terms of cardiovascular benefits and adverse effects. It delves into the mechanism of action of these drugs, their impact on mortality rates, and the challenges in evaluating their risk versus reward due to limited usage and high cost. The conversation also explores the complexities of assessing cardiovascular risk factors beyond just LDL cholesterol levels, emphasizing a comprehensive approach to improve heart health.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode